Our study expanded on the epigenetic regulatory mechanism of SALL4 expression in glioma, highlighting the clinical importance of miR-103, miR-195, and miR-15b/SALL4 in the future treatment of glioma. Here, SALL4 is linked to central nervous system cancer.